BIO vs CBZ · rev $651.0M vs P/E 63, rev $1.53B
BIO (BIO) versus CBIZ Inc (CBZ) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
CBIZ Inc (CBZ) is a specialty business services company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported CBZ revenue for 2026-06-30 was $1.53B. Net income was $171.4M. Revenue was up 120.6% from 2025-09-30 to 2026-06-30. CBZ currently screens at market cap $3.98B and trailing P/E 63.1.
BIO currently screens at market cap $0. CBZ currently screens at market cap $3.98B and trailing P/E 63.1.
Not investment advice. Open the BIO and CBZ stock pages for the full models.
Not investment advice.